Compass Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Compass Therapeutics using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $-0.08 | $-0.14 | 42.9 % |
| Q2 | 2025-08-11 | $-0.14 | $-0.12 | -16.7 % |
| Q1 | 2025-05-08 | $-0.12 | $-0.11 | -9.09 % |
| Q4 | 2025-02-27 | $-0.11 | $-0.09 | -22.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
Compass Therapeutics (CMPX) is scheduled to report earnings on February 26, 2026. The last reported earnings were for reported on November 5, 2025 for Q3.
The Actual EPS was $-0.08, which beat the estimate of $-0.14.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.